GlassScriptPhysician profile
Matthew O Old
NPI 1699891242
$10,128.96
in general payments reported to CMS, 2019-2025
8 companies · $1,208 in 2025
The $1,208 reported for 2025 was more than what 83% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.35 · 2020: $83.61 · 2021: $4,019 · 2022: $4,124 · 2023: $298 · 2024: $332 · 2025: $1,208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,181 · Travel and Lodging: $657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,181.27 |
| Travel and Lodging | $657.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $5,337.19 | 2019-2025 | |
| Intuitive Surgical, INC. | $3,528.98 | 2021 | |
| Medical Device Business Services, INC. | $877.47 | 2025 | Matrixcombo |
| Axogen | $267.62 | 2024-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Acera Surgical, INC. | $72.25 | 2025 | Restrata Wound Matrix |
| Integra Lifesciences Corporation | $45.45 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Old listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.